Organization

Humacyte, Inc.

About

Humacyte is a biotechnology company that develops and manufactures bioengineered off-the-shelf, universally implantable human tissues. The regenerative vascular conduit, Humacyte Human Acellular Vessel (HAV), is currently in various stages of clinical trials that are targeting multiple vascular applications. Their platform technology also has potential applications and solutions for complex organ disease, including replacement tissues or organs for coronary grafts, pediatric heart surgery, and Type 1 diabetes treatment.

Overview

Founded 2004
Type Public
Location North Carolina, USA

Stock

HUMA $3.36 -5.35% $(0.19)

Latest News

Livent, Amgen And Some Other Big Stocks Moving Lower On Monday Sep 12, 2022 Benzinga U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today’s session....
Humacyte Announces Presentation on Investigational Human Acellular VesselTM for Treatment of Vascular Trauma at the International Committee of Military Medicine World Congress Sep 09, 2022 GlobeNewswire Inc. Dr. Todd E. Rasmussen provides HAV™ clinical update and surgical skills workshop at ICMM Dr. Todd E. Rasmussen provides HAV™ clinical update and surgical skills...
Humacyte Presents at Multiple Conferences in September 2022 Sep 08, 2022 GlobeNewswire Inc. DURHAM, N.C., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissues and complex...
Wall Street Analysts See an 85% Upside in Humacyte, Inc. (HUMA): Can the Stock Really Move This High? Aug 17, 2022 Zacks Investment Research The consensus price target hints at an 84.8% upside potential for Humacyte, Inc. (HUMA). While empirical research shows that this sought-after metric is hardly effective,...
Humacyte Second Quarter 2022 Financial Results and Business Update Aug 12, 2022 GlobeNewswire Inc. -- Human Acellular Vessels™ (HAVs™) successfully implanted in wounded Ukrainian citizens and reported to be functioning, saving limbs –